3rd Party LMP1/2-Specific Cytotoxic T Lymphocytes for EBV-Associated Lymphoma
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT02057445 |
|
Recruitment Status :
Completed
First Posted : February 7, 2014
Last Update Posted : December 22, 2017
|
Sponsor:
New York Medical College
Collaborators:
Children's National Research Institute
Baylor College of Medicine
M.D. Anderson Cancer Center
University of Michigan
University of Utah
City of Hope Medical Center
Ohio University
Johns Hopkins University
Information provided by (Responsible Party):
Mitchell Cairo, New York Medical College
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Recruitment Status : | Completed |
|---|---|
| Actual Primary Completion Date : | December 2016 |
| Actual Study Completion Date : | December 2017 |